Announced
Synopsis
KKR, a leading global investment firm has agreed to invest in AcuFocus, a privately held ophthalmic medical device company, for $66m. The financing round led by KKR will allow AcuFocus to accelerate its commercialization plans for the KAMRA inlay and IC-8 lens as well as further advances in research and development projects that continue to leverage its small aperture expertise. “We are honored that KKR has chosen to make AcuFocus its first investment in the ophthalmic space. Through this partnership, and the continued support of our current investors, we look forward to driving the company into a global market leadership position in presbyopia and cataract surgery.” Bill Link, AcuFocus Chairman of the Board.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.